The study supports the utility of DSIP-CBBBP in developing therapies targeting neurotransmitter dysregulation and sleep disturbances, offering a promising avenue for future research in sleep-related treatments
This resistance can lead to energy crashes, sugar cravings, and difficulty maintaining stable blood sugar levels
Semaglutide's side effectsnausea, reduced appetite, and early satietycan make hitting protein targets difficult, making nutritional strategy essential during GLP-1 therapy
However, when a third of the participants were switched to a placebo for the following year, they regained 7% of the weight they had lost
However, the temporal dynamics and mechanisms underlying insulin resistance development in AD remain unclear